New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer.

Area of Science:

• Oncology
• Microbiology
• Radiotherapy

Background:

• Cancer is a leading global cause of death with complex development mechanisms.
• Gut microbiota composition and modification are increasingly recognized for their role in various cancers.
• The gut-organ axis represents a novel area of investigation in cancer research.

Purpose of the Study:

• To review the intricate relationship between gut microbiota, cancer, and radiotherapy.
• To explore how gut microbiota modifications impact cancer radiosensitivity and treatment outcomes.
• To provide an overview of emerging cancer therapies targeting the gut microbiota.

Main Methods:

• Literature review synthesizing current research findings.
• Analysis of bidirectional interactions between gut microbiota and cancer radiotherapy.
• Exploration of the gut-organ axis concept in cancer biology.

Main Results:

• Gut microbiota significantly influences cancer development and progression.
• Radiotherapy-induced gut microbiota alterations affect tumor radiosensitivity and treatment efficacy.
• Gut microbiota modifications contribute to radiotherapy toxicity and side effects.

Conclusions:

• The gut microbiota plays a crucial role in cancer radiotherapy.
• Targeting the gut microbiota offers potential for novel cancer treatment strategies.
• Further research into the gut-organ axis is warranted for therapeutic advancements.